Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region

Journal of Neuroscience

Volumn 19, Issue 4, 1999, Pages 1437-1445

  Otmakhova, Nonna A ^a   Lisman, John E ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

AMPA; CA1; Clozapine; D1; D2; Dopamine; Eticlopride; GABA(A); Haloperidol; Hippocampus; NMDA; Perforant path; SCH 23390; Schaffer collaterals; Schizophrenia; U 101958

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; ETICLOPRIDE; HALOPERIDOL; N (1 BENZYL 4 PIPERIDINYL) N (3 ISOPROPOXY 2 PYRIDINYL) N METHYLAMINE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FACILITATION; HIPPOCAMPUS; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA; SENSORY STIMULATION;

EID: 0033558085     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-04-01437.1999     Document Type: Article

References (84)

1. Acquas E, Day JC, Fibiger HC (1994) The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. Eur J Pharmacol 260:85-87.
2. Aguayo LG, Grossie J (1994) Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adull rat sympathetic neurons. J Pharmacol Exp Ther 269:503-508.
3. Ault B, Nadler JV (1982) Baclofen selectively inhibits transmission at synapses made by axons of CA3 pyramidal cells in the hippocampal slice. J Pharmacol Exp Ther 223:291-297.
4. Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM (1992) Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry [Suppl]17:12-16.
5. Baude A, Nusser Z, Molnar E, McIlhinney RA, Somogyi P (1995) High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus. Neuroscience 69:1031-1055.
6. Bazin N, Perruchet P (1996) Implicit and explicit associative memory in patients with schizophrenia. Schizophr Res 22:241-248.
7. Benke TA, Luthi A, Isaac JT, Collingridge GL (1998) Modulation of AMPA receptor unitary conductance by synaptic activity. Nature 393:793-797.
8. Bernabeu R, Bevilaqua L, Ardenghi P, Bromberg E, Schmitz P, Bianchin M, Izquierdo I, Medina JH (1997) Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats. Proc Natl Acad Sci USA 94:7041-7046.
9. Bertorello AM, Hopfield JF, Aperia A, Greengard P (1990) Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 347:386-388.
10. Berzhanskaya J, Urban NN, Barrionuevo G (1998) Electrophysiological and pharmacological characterization of the direct perforant path input to hippocampal area CA3. J Neurophysiol 79:2111-2118.
11. Bilder RM, Bogerts B, Ashtari M, Wu H, Alvir JM, Jody D, Reiter G, Bell L, Lieberman JA (1995) Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res 17:47-58.
12. Bogerts B, Falkai P (1995) Postmortem brain abnormalities in schizophrenia. In: Contemporary issues in the treatment of schizophrenia (Shriqui CL, Nasrallah HA, eds), pp 43-59. Washington, DC: American Psychiatric.
13. Bragin AG, Otmakhov NA (1979a) Comparison of direct influences of the perforant path on hippocampal CA1 and CA3 neurons in vitro. Neurophysiology 11:220-225.
14. Bragin AG, Otmakhov NA (1979b) Investigation of heterosynaptic interactions in hippocampal areas CA1 and CA3 in vitro. Neurophysiology 11:389-396.
15. Brehion G, Smith MJ, Gorman JM, Amador X (1996) Reality monitoring failure in schizophrenia: the role of selective attention. Schizophr Res 22:173-180.
16. Bunney BS (1992) Clozapine: a hypothesised mechanism for its unique clinical profile. Br J Psychiatry [Suppl]:17:17-21.
17. Buzsaki G (1989) Two-stage model of memory trace formation: a role for "noisy" brain states. Neuroscience 31:551-570.
18. Calabresi P, Maj R, Mercuri NB, Bernardi G (1992) Coactivalion of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett 142:95-99.
19. Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol [Suppl] 3:21-28.
20. Carr DB, Sesack SR (1996) Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369:1-15.
21. Colbert CM, Levy WB (1992) Electrophysiological and pharmacological characterization of perforant path synapses in CA1: mediation by glutamate receptors. J Neurophysiol 68:1-8.
22. Coward DM (1992) General pharmacology of clozapine. Br J Psychiatry [Suppl]:17:5-11.
23. Deadwyler SA, Hampson RE (1997) The significance of neural ensemble codes during behavior and cognition. Annu Rev Neurosci 20:217-244.
24. Defagot MC, Malchiodi EL, Villar MJ, Antonelli MC (1997) Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res 45:1-12.
25. Deicken RF, Calabrese G, Merrin EL, Vinogradov S, Fein G, Weiner MW (1995) Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31 phosphorous magnetic resonance spectroscopic imaging study. Biol Psychiatry 38:279-286.
26. Delle Donne KT, Sesack SR, Pickel VM (1997) Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res 746:239-255.
27. Dolleman-Van der Weel MJ, Lopes da Silva FH, Witter MP (1997) Nucleus reuniens thalami modulates activity in hippocampal field CA1 through excitatory and inhibitory mechanisms. J Neurosci 17:5640-5650.
28. Doller HJ, Weight FF (1982) Perforant pathway activation of hippocampal CA1 stratum pyramidale neurons: electrophysiological evidence for a direct pathway. Brain Res 237:1-13.
29. Eichenbaum H (1997) Declarative memory: insights from cognitive neurobiology. Annu Rev Psychol 48:547-572.
30. Empson RM, Heinemann U (1995) Perforant path connections to area CA1 are predominantly inhibitory in the rat hippocampal-entorhinal cortex combined slice preparation. Hippocampus 5:104-107.
31. Frey U, Huang Y-Y, Kandel E (1993) Effects of cAMP stimulate a late stage of LTP in hippocampal CA1 neurons. Science 260:1661-1664.
32. Fukuzako H, Kodama S, Fukuzako T, Yamada K, Hokazono Y, Ueyama K, Hashiguchi T, Takenouchi K, Takigawa M, Takeuchi K, Manchandza S (1995) Shortening of the hippocampal formation in first-episode schizophrenic patients. Psychiatry Clin Neurosci 49:157-161.
33. Gasbarri A, Sulli A, Innocenzi R, Pacitti C, Brioni JD (1996) Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience 74:1037-1044.
34. Goldsmith S, Joyce J (1994) Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4:354-373.
35. Gray NS, Pilowsky LS, Gray JA, Kerwin RW (1995) Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res 17:95-107.
36. Grecksch G, Matthies H (1982) Involvement of hippocampal dopaminergic receptors in memory consolidation in rats. In: Neuronal plasticity and memory formation (Marsan C, Matthies H, eds), pp 353-357. New York: Raven.
37. Gribkoff VK, Ashe JH (1984) Modulation by dopamine of population responses and cell membrane properties of hippocampal CA1 neurons in vitro. Brain Res 292:327-338.
38. Hajos-Korcsok E, Sharp T (1996) 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. Eur J Pharmacol 314:285-291.
39. Halberstadt AL (1995) The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249.
40. Hasselmo ME, Schnell E (1994) Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: computational modeling and brain slice physiology. J Neurosci 14:3898-3914.
41. Heckers S, Rauch S, Golf D, Savage G, Schaster D, Fischman A, Alpert N (1998) Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1:318-323.
42. Hersi AI, Richard JW, Gaudrcau P, Quirion R (1995) Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study. J Neurosci 15:7150-7157.
43. Hsu KS (1996) Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. J Neurophysiol 76:1887-1895.
44. Hu XT, White FJ (1997) Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neurosci Lett 224:61-65.
45. Jackson D, Mohell N (1996) A review of the pharmacology of new antipsychotic drugs. In: CNS neurotransmitters and neuromodulators: dopamine (Stone T, ed), pp 185-200. Boca Raton: CRS.
46. Javitt DC (1996) Glutamate receptors and schizophrenia: opportunities and caveats [news]. Mol Psychiatry 1:16-17.
47. Jensen O, Idiart M, Lisman JE (1996) Physiologically realistic formation of autoassociative memory in networks with theta/gamma oscillations: role of fast NMDA channels. Learning and Memory 3:243-256.
48. Joyce JN (1993) The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology (Berl) 112:S16-S34.
49. Joyce JN, Meador-Woodruff JH (1997) Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology 16:375-384.
50. Keefe KA, Gerfen CR (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66:903-913.
51. Knaus HG, Schwarzer C, Koch RO, Eberhart A, Kaczorowski GJ, Glossmann H, Wunder F, Pongs O, Garcia ML, Sperk G (1996) Distribution of high-conductance Ca(2+)-activatcd K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci 16:955-963.
52. Levy WB (1989) A computational approach to hippocampal function. In: Computational models of learning in simple neural systems (Hawkins RD, Bower GH, eds), pp 243-305. New York: Academic.
53. Levy WB, Colbert CM, Desmond NL (1995) Another network model bites the dust: entorhinal inputs are no more than weakly excitatory in the hippocampal CA1 region. Hippocampus 5:137-140.
54. Lewis DA, Sesack SR, Levey AI, Rosenberg DR (1998) Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol 42:703-706.
55. Lopes da Silva FH, Witter MP, Boeijinga PH, Lohman AH (1990) Anatomic organization and physiology of the limbic cortex. Physiol Rev 70:453-511.
56. Malenka RC, Nicoll RA (1986) Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells. Brain Res 379:210-215.
57. Marciani MG, Calabresi P, Stanzione P, Bernardi G (1984) Dopaminergic and noradrenergic responses in the hippocampal slice preparation. Evidence for different receptors. Neuropharmacology 23:303-307.
58. McNaughton BL, Barnes CA, Meltzer J, Sutherland RJ (1989) Hippocampal granule cells are necessary for normal spatial learning but not for spatially-selective pyramidal cell discharge. Exp Brain Res 76:485-496.
59. Meltzer HY (1994) An overview of the mechanism of action of clozapine. J Clin Psychiatry [Suppl] 55:47-52.
60. Momiyama T, Sasa M, Takaori S (1993a) Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area. Br J Pharmacol 110:713-718.
61. Momiyama T, Todo N, Sasa M (1993b) A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopamincrgic neurones in the ventral tegmental area in vitro. Br J Pharmacol 109:933-940.
62. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS (1996) Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248.
63. Neki A, Ohishi H, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1996) Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett 202:197-200.
64. Newman-Taneredi A, Audinot-Bouchez V, Gobert A, Millan MJ (1997) Noradrenaline and adrenaline arc high affinity agonists at dopamine D4 receptors. Eur J Pharmacol 319:379-83.
65. O'Keefe J (1993) Hippocampus, theta, and spatial memory. Curr Opin Neurobiol 3:917-924.
66. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
67. Otmakhova NA, Lisman JE (1996) D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J Neurosci 16:7478-7486.
68. Otmakhova NA, Lisman JE (1998) D1/D5 dopamine receptors inhibit depotentiation at CA1 synapses via cAMP-dependent mechanism. J Neurosci 18:1270-1279.
69. Packard MG, White NM (1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 105:295-306.
70. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353:164-167.
71. Pockett S (1985) Dopamine changes the shape of action potentials in hippocampal pyramidal cells. Brain Res 342:386-390.
72. Schlachter SK, Poel TJ, Lawson CF, Dinh DM, Lajiness ME, Romero AG, Rees SA, Duncan JN, Smith MW (1997) Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor. Eur J Pharmacol 322:283-286.
73. Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Niethammer R (1995) Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 28:38-45.
74. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW (1992) Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med 327:604-612.
75. Shi WX, Smith PL, Pun CL, Millet B, Bunney BS (1997) D1-D2 interaction in feedback control of midbrain dopamine neurons. J Neurosci 17:7988-7994.
76. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Jones T, Frackowiak RSJ (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176-179.
77. Skaggs WE, McNaughton BL (1992) Computational approaches to hippocampal function. Curr Opin Neurobiol 2:209-211.
78. Spencer W, Kandel E (1962) Hippocampal neuron responses in relation to normal and abnormal function. In: Physiologiede l'hippocampe, (Passouant P. ed), pp 71-103. Paris: Centre National de la Recherche Scientifique.
79. Surmeier DJ, Kitai ST (1993) D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons. Prog Brain Res 99:309-324.
80. Swanson L, Kohler C, Bjorklund A (1987) The limbic region. I: The septohippocampal system. In: Integrated systems of the CNS (Bjorklund A, Hokfelt T, Swanson L, eds), pp 125-269. New York: Elsevier Science.
81. Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE (1995) Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry 52:1061-1070.
82. Vinogradova O (1984) Functional organization of the limbic system in the process of registration of information: facts and hypotheses. In: The hippocampus (Isaacson RL, Pribram KH, eds), pp 1-69. New York: Plenum.
83. Wan FJ, Taaid N, Swerdlow NR (1996) Do D1/D2 interactions regulate propulse inhibition in rats? Neuropsychopharmacology 14:265-274.
84. Yeckel MF, Berger TW (1990) Feedforward excitation of the hippocampus by afferents from the entorhinal cortex: redefinition of the role of the trisynaptic pathway. Proc Natl Acad Sci USA 87:5832-5836.